Tectonic Therapeutic, Inc. — Director's Dealing 2023

Feb 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2023-02-08

Reporting Person: MACKAY GEOFFREY (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-08	Restricted Stock Unit	$0	A	300667	Acquired	2027-02-01	Common Stock (300667)	Direct

Footnotes

F1: The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.